Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society
[Preface] In 2005, intravenous (IV) thrombolysis using alteplase, a recombinant tissue, type plasminogen activator (rt-PA), for patients with acute ischemic stroke was approved in Japanon the basis of the results of the Japan Alteplase Clinical Trial (J-ACT) with a specific low-dose regimen. Over th...
Saved in:
Published in | Neurologia medico-chirurgica Vol. 59; no. 12; pp. 449 - 491 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
The Japan Neurosurgical Society
2019
THE JAPAN NEUROSURGICAL SOCIETY Japan Science and Technology Agency |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!